KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Gross Profit: 2009-2025

Historic Gross Profit for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $1.9 billion.

  • Bausch Health Companies' Gross Profit rose 6.46% to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 billion, marking a year-over-year increase of 5.78%. This contributed to the annual value of $6.9 billion for FY2024, which is 10.55% up from last year.
  • According to the latest figures from Q3 2025, Bausch Health Companies' Gross Profit is $1.9 billion, which was up 9.20% from $1.8 billion recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Gross Profit ranged from a high of $6.6 billion in Q4 2021 and a low of $1.4 billion during Q1 2023.
  • For the 3-year period, Bausch Health Companies' Gross Profit averaged around $1.7 billion, with its median value being $1.7 billion (2024).
  • Its Gross Profit has fluctuated over the past 5 years, first skyrocketed by 320.81% in 2021, then plummeted by 76.57% in 2022.
  • Bausch Health Companies' Gross Profit (MRQ) stood at $6.6 billion in 2021, then plummeted by 76.57% to $1.6 billion in 2022, then rose by 10.23% to $1.7 billion in 2023, then rose by 7.88% to $1.8 billion in 2024, then rose by 5.30% to $1.9 billion in 2025.
  • Its Gross Profit was $1.9 billion in Q3 2025, compared to $1.8 billion in Q2 2025 and $1.6 billion in Q1 2025.